Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 60

Results For "IoT"

1335 News Found

Apollo Hospitals Enterprise reduces stake in Apollo Home Healthcare
News | December 27, 2023

Apollo Hospitals Enterprise reduces stake in Apollo Home Healthcare

AHHL is primarily engaged in nursing care, in home primary care, physiotherapy at home, sample collection, post-operative/post-surgical care


BioVaxys executes LoI for major Immunotherapeutics technology acquisition
News | December 26, 2023

BioVaxys executes LoI for major Immunotherapeutics technology acquisition

BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement


UPM Biomedicals enters into distribution agreement with Brinter for GrowInk bioinks
Supply Chain | December 23, 2023

UPM Biomedicals enters into distribution agreement with Brinter for GrowInk bioinks

The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries


AGC invests US$ 348 million to expand its biopharmaceutical CDMO capability
News | December 21, 2023

AGC invests US$ 348 million to expand its biopharmaceutical CDMO capability

Development services for gene and cell therapies is planned to begin first in 2025


Asahi Kasei opens new Bioprocess Technical Center in China
News | December 20, 2023

Asahi Kasei opens new Bioprocess Technical Center in China

The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics


Biocon Academy conducts 8th Graduation Day
News | December 19, 2023

Biocon Academy conducts 8th Graduation Day

Five batches across four programs of Biocon Academy participated in the graduation ceremony


Biocon Biologics recognized as an Asia IP Elite for 2023
News | December 17, 2023

Biocon Biologics recognized as an Asia IP Elite for 2023

Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list


ExeGi Pharma announces first patient enrollment in the PROF Trial of EXE-346
News | December 10, 2023

ExeGi Pharma announces first patient enrollment in the PROF Trial of EXE-346

First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes


Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets in US
Drug Approval | December 02, 2023

Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets in US

Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US


Fosun Pharma USA and Treehill Partners to invest in biopharma space
News | November 23, 2023

Fosun Pharma USA and Treehill Partners to invest in biopharma space

The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market